Recent Updates
Recently added Catalysts
VSTM Positive Sentiment

Verastem Oncology to Participate in Upcoming November Investor Conferences

Monday, November 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Verastem Oncology announced its participation in three upcoming investor conferences. The management team will present at the Guggenheim Healthcare Innovation Conference on November 9, followed by the Wolfe Research Healthcare Conference on November 10, and the Jefferies London Healthcare Conference. This engagement highlights the company's focus on advancing treatments for RAS/MAPK pathway-driven cancers.

Market Sentiment Analysis

POSITIVE FACTORS

  • Verastem Oncology is actively engaging with investors.
  • Management will present at three notable conferences.
  • Focus on RAS/MAPK pathway-driven cancers shows commitment.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+193%
120-day peak, hindsight
Typical move
7.8%
average across 9 past catalysts
Cash runway
~7 mo
Medium dilution risk
Lead asset
VS-7375
Phase 2 · Pancreatic Ductal Adenocarcinoma

Full Press Release Details

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to present at the following investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference in Boston: November 9, 4:00-4:25pm ET Wolfe Research Healthcare Conference in New York City: November 10, 4:00-4:30pm ET Jefferies London Healthcare Conference in Lo

Frequently Asked Questions

When will Verastem present at the Guggenheim Conference?

Verastem will present on November 9 from 4:00 to 4:25 PM ET.

What is the focus of Verastem Oncology?

The company focuses on advancing medicines for RAS/MAPK pathway-driven cancers.

Where is the Wolfe Research Healthcare Conference held?

The Wolfe Research Healthcare Conference is in New York City.

What dates are the upcoming investor conferences?

The conferences are on November 9 and 10.

ShareAdd on Google
Tags: VSTM Verastem Oncology investor conferences RAS/MAPK healthcare innovation
Last updated: Nov 2, 2026

Biotech snapshot

Cash runway
$136M liquidity · $15M/mo burn
~7 mo
Medium dilution risk
Lead asset
VS-7375Phase 2
Pancreatic Ductal Adenocarcinoma →

Catalyst track record

+193%
best trade around VSTM's most recent catalyst

Peak hindsight return over a 120-day window, across 9 tracked FDA/PDUFA catalysts for VSTM.

See every catalyst's timing & PoA →